Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Para-aortic lymphadenectomy can be omitted in most endometrial cancer patients at risk of lymph node metastasis.

Baiocchi G, Faloppa CC, Mantoan H, Camarço WR, Badiglian-Filho L, Kumagai LY, De Brot L, da Costa AABA.

J Surg Oncol. 2017 May 8. doi: 10.1002/jso.24651. [Epub ahead of print]

PMID:
28482122
2.

Is parametrectomy always necessary in early-stage cervical cancer?

Baiocchi G, de Brot L, Faloppa CC, Mantoan H, Duque MR, Badiglian-Filho L, da Costa AABA, Kumagai LY.

Gynecol Oncol. 2017 Jul;146(1):16-19. doi: 10.1016/j.ygyno.2017.03.514. Epub 2017 Apr 6.

PMID:
28392128
3.

Does para-aortic irradiation reduce the risk of distant metastasis in advanced cervical cancer? A systematic review and meta-analysis of randomized clinical trials.

Sapienza LG, Gomes MJL, Calsavara VF, Leitao MM Jr, Baiocchi G.

Gynecol Oncol. 2017 Feb;144(2):312-317. doi: 10.1016/j.ygyno.2016.11.044. Epub 2016 Nov 28. Review.

PMID:
27908530
4.

Infections with multiple high-risk HPV types are associated with high-grade and persistent low-grade intraepithelial lesions of the cervix.

De Brot L, Pellegrini B, Moretti ST, Carraro DM, Soares FA, Rocha RM, Baiocchi G, da Cunha IW, de Andrade VP.

Cancer. 2017 Feb;125(2):138-143. doi: 10.1002/cncy.21789. Epub 2016 Nov 21.

PMID:
27870295
5.

Volumetric (3D) bladder dose parameters are more reproducible than point (2D) dose parameters in vaginal vault high-dose-rate brachytherapy.

Sapienza LG, Flosi A, Aiza A, de Assis Pellizzon AC, Chojniak R, Baiocchi G.

Sci Rep. 2016 Jun 14;6:28074. doi: 10.1038/srep28074.

6.

An Integrative Approach Uncovers Biomarkers that Associate with Clinically Relevant Disease Outcomes in Vulvar Carcinoma.

Lavorato-Rocha AM, Akagi EM, de Melo Maia B, Rodrigues IS, Botelho MC, Marchi FA, Fernandes G, Baiocchi G, Soares FA, Rogatto SR, Sato-Kuwabara Y, Rocha RM.

Mol Cancer Res. 2016 Aug;14(8):720-9. doi: 10.1158/1541-7786.MCR-15-0366. Epub 2016 May 11.

PMID:
27170308
7.

May Sonic Hedgehog proteins be markers for malignancy in uterine smooth muscle tumors?

Garcia N, Bozzini N, Baiocchi G, da Cunha IW, Maciel GA, Soares Junior JM, Soares FA, Baracat EC, Carvalho KC.

Hum Pathol. 2016 Apr;50:43-50. doi: 10.1016/j.humpath.2015.08.026. Epub 2015 Nov 24.

PMID:
26997437
8.

TOP2A copy number and TOP2A expression in uterine benign smooth muscle tumours and leiomyosarcoma.

Baiocchi G, Poliseli FL, De Brot L, Mantoan H, Schiavon BN, Faloppa CC, Vassallo J, Soares FA, Cunha IW.

J Clin Pathol. 2016 Oct;69(10):884-9. doi: 10.1136/jclinpath-2015-203561. Epub 2016 Mar 18.

PMID:
26994023
9.

An uncommon response to metronomic therapy in a heavily pretreated patient with metastatic carcinosarcoma: a case report.

Gagliato Dde M, Linck RD, Bezerra RO, Souto M, Lopes GL, Baiocchi G, Mano MS.

J Med Case Rep. 2016 Mar 14;10:60. doi: 10.1186/s13256-016-0837-3. Review.

10.

The Value of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer and Application of a Prognostic Score.

da Costa AA, Valadares CV, Mantoan H, Saito A, Salvadori MM, Guimarães AP, Sanches SM, Achatz MI, Baiocchi G.

Int J Gynecol Cancer. 2016 Mar;26(3):449-55. doi: 10.1097/IGC.0000000000000649.

PMID:
26825830
11.

Hyperthermic Intraperitoneal Chemotherapy after Secondary Cytoreduction in Epithelial Ovarian Cancer: A Single-center Comparative Analysis.

Baiocchi G, Ferreira FO, Mantoan H, da Costa AA, Faloppa CC, Kumagai LY, de Mello CA, Takahashi RM, Nakagawa WT, Aguiar S Jr, Lopes A.

Ann Surg Oncol. 2016 Apr;23(4):1294-301. doi: 10.1245/s10434-015-4991-4. Epub 2015 Dec 1.

PMID:
26628430
12.

Bladder (ICRU) dose point does not predict urinary acute toxicity in adjuvant isolated vaginal vault high-dose-rate brachytherapy for intermediate-risk endometrial cancer.

Sapienza LG, Aiza A, Gomes MJ, Chen MJ, Pellizzon AC, Mansur DB, Baiocchi G.

J Contemp Brachytherapy. 2015 Oct;7(5):357-62. doi: 10.5114/jcb.2015.54952. Epub 2015 Oct 13.

13.

Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer.

da Costa AA, Valadares CV, Baiocchi G, Mantoan H, Saito A, Sanches S, Guimarães AP, Achatz MI.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S971-8. doi: 10.1245/s10434-015-4623-z. Epub 2015 May 27.

PMID:
26014155
14.

Dermatofibrosarcoma protuberans of the vulva: margins assessment and reconstructive options - a report of two cases.

Bertolli E, Bretchbuhl ER, Camarço WR, Campagnari M, Molina AS, Baiocchi G, Macedo MP, Pinto CA, Cunha IW, Neto JP.

World J Surg Oncol. 2014 Dec 29;12(1):399. [Epub ahead of print]

15.

Can a sentinel node mapping algorithm detect all positive lymph nodes in cervical cancer?

de Freitas RR, Baiocchi G, Hatschbach SB, Linhares JC, Guerreiro JA, Minari CL, Ribeiro R, Jung J, Zukovski T, Lopes A.

Ann Surg Oncol. 2015 May;22(5):1564-9. doi: 10.1245/s10434-014-4245-x. Epub 2014 Nov 18.

PMID:
25404479
16.

ROCK1 as a novel prognostic marker in vulvar cancer.

Akagi EM, Lavorato-Rocha AM, Maia Bde M, Rodrigues IS, Carvalho KC, Stiepcich MM, Baiocchi G, Sato-Kuwabara Y, Rogatto SR, Soares FA, Rocha RM.

BMC Cancer. 2014 Nov 7;14:822. doi: 10.1186/1471-2407-14-822.

17.

Natural history and surgical treatment of chordoma: a retrospective cohort study.

Aguiar Júnior S, Andrade WP, Baiocchi G, Guimarães GC, Cunha IW, Estrada DA, Suzuki SH, Kowalski LP, Lopes A.

Sao Paulo Med J. 2014;132(5):297-302. Epub 2014 Jul 29.

18.

EGFR expression in vulvar cancer: clinical implications and tumor heterogeneity.

de Melo Maia B, Fontes AM, Lavorato-Rocha AM, Rodrigues IS, de Brot L, Baiocchi G, Stiepcich MM, Soares FA, Rocha RM.

Hum Pathol. 2014 May;45(5):917-25. doi: 10.1016/j.humpath.2014.01.015. Epub 2014 Jan 31.

PMID:
24746196
19.

Cox-2, EGFR, and ERBB-2 expression in cervical intraepithelial neoplasia and cervical cancer using an automated imaging system.

Fukazawa EM, Baiocchi G, Soares FA, Kumagai LY, Faloppa CC, Badiglian-Filho L, Coelho FR, Gonçalves WJ, Costa RL, Góes JC.

Int J Gynecol Pathol. 2014 May;33(3):225-34. doi: 10.1097/PGP.0b013e318290405a.

PMID:
24681731
20.

NF-κB and COX-2 expression in nonmalignant endometrial lesions and cancer.

Faloppa CC, Baiocchi G, Cunha IW, Fregnani JH, Osorio CA, Fukazawa EM, Kumagai LY, Badiglian-Filho L, Pinto GL, Soares FA.

Am J Clin Pathol. 2014 Feb;141(2):196-203. doi: 10.1309/AJCPV7U7PGHOWEQG.

PMID:
24436266

Supplemental Content

Loading ...
Support Center